Erratum: Combination treatment of mannose and GalNAc conjugated small interfering RNA protects against lethal Marburg virus infection (Molecular Therapy (2023) 31(1) (269–281), (S1525001622005639), (10.1016/j.ymthe.2022.09.009))

Xin Ye, Richard Holland, Mark Wood, Chris Pasetka, Lorne Palmer, Eleni Samaridou, Kevin McClintock, Viktoriya Borisevich, Thomas W. Geisbert, Robert W. Cross, James Heyes

Research output: Contribution to journalComment/debatepeer-review

Abstract

(Molecular Therapy 31, 269–281; January 2023) In the originally published version of this article, Figure S9 was included with an error. Incorrect images were copied to the fluorescent microscopic images for the 5 ug/mL Cy3-tetra-mannose-siCD45 and 5 ug/mL Cy3-tetra-GalNAc-siCD45 treated samples. This error has been corrected online with the inclusion of the correct images. The authors sincerely apologize for this error.[Formula

Original languageEnglish (US)
Pages (from-to)911-912
Number of pages2
JournalMolecular Therapy
Volume31
Issue number3
DOIs
StatePublished - Mar 1 2023

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Erratum: Combination treatment of mannose and GalNAc conjugated small interfering RNA protects against lethal Marburg virus infection (Molecular Therapy (2023) 31(1) (269–281), (S1525001622005639), (10.1016/j.ymthe.2022.09.009))'. Together they form a unique fingerprint.

Cite this